Diabetes prevention program tailored for native men shows promise
NCT ID NCT02952352
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a diabetes prevention program adapted for American Indian men living on the Colville reservation. Overweight and obese men without diabetes took part in a culturally informed program aimed at weight loss and reducing diabetes risk. The trial enrolled 113 men and measured changes in weight, blood pressure, and readiness to change habits.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- culturally adapted diabetes prevention program
- What this could lead to
- If successful, this approach could offer an effective way to prevent diabetes in American Indian communities.
- What could go wrong
- This was a small, single-site study with 113 men, so results may not apply to other groups or settings. Weight loss can be hard to maintain long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Confederated Tribes of the Colville Reservation
Nespelem, Washington, 99155, United States
-
IREACH
Seattle, Washington, 98101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins